Fig. 5From: SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signalingSLERT activates BDNF/TRKB signaling. A, B Western blot testing BDNF, TRKB and E-caderin protein levels in SLERT-overexpressed KLE and AN3CA cells transfected with METTL3 or BDNF siRNA. C, D Transwell assay testing the invasion of SLERT-overexpressed KLE and AN3CA cells transfected with METTL3 or BDNF siRNA. *P<0.05, **P<0.01Back to article page